SIX Exchange: Nobel Biocare Holding Ltd, Kloten to be delisted

ZURICH, 4-2-2015 — /EuropaWire/ — On 19 January 2015, Nobel Biocare Holding Ltd, Kloten (Swiss Security Number 3’785’164 / ISIN CH0037851646) applied for the delisting of all of its listed registered shares with a par value of CHF 0.40 each. SIX Exchange Regulation granted this application on 3 February 2015. The delisting takes place on a still to be determined date and will be announced by means of an official notice five trading days prior to the last trading date of the shares on SIX Swiss Exchange.

SIX Exchange Regulation publishes its decision with grounds regarding the delisting on its website under the following link:

The applicable directive is available under:

Should you have any questions, please feel free to contact Stephan Meier, Media Relations.
Phone: +41 58 399 3290
Fax: +41 58 499 2710

SIX Exchange Regulation
SIX Exchange Regulation performs the functions assigned under Swiss federal law and enforces and monitors compliance with the rules laid down by the Regulatory Board. SIX Exchange Regulation imposes sanctions in so far as it is authorised to do so by the regulations, or submits sanction requests to SIX Swiss Exchange’s Sanction Commission.

SIX Exchange Regulation’s independence from SIX Swiss Exchange’s operating business is guaranteed by its direct subordination to the Chairman of the Board of Directors of SIX Group. SIX Exchange Regulation consists of the divisions Listing & Enforcement, responsible for regulating issuers, and Surveillance & Enforcement monitoring trading.

SIX operates Switzerland’s financial market infrastructure and offers on a global scale comprehensive services in the areas of securities trading, clearing and settlement, as well as financial information and payment transactions. The company is owned by its users (approximately 140 banks of various size and orientation) and, with its workforce of more than 3‚700 employees and presence in 24 countries, generated an operating income of 1.58 billion Swiss francs and a Group net profit of CHF 210.2 million in 2013.


Comments are closed.